Keywords:
Musculoskeletal spine, Fluoroscopy, Complications, Drugs / Reactions
Authors:
W. Y. Kang1, J. W. Lee2; 1Cheongju-si/KR, 2Seongnam/KR
DOI:
10.1594/essr2018/P-0124
Purpose
Epidural steroid injections (ESI) has been used in the treatment of radicular pain caused by herniated intervertebral disc or spinal canal stenosis.
Although ESI are widely used as an effective treatment for spinal origin pain,
there is still a debate about its safety.
4-23-2014, U.S.
Food and Drug Administration (FDA) warned that injection of corticosteroids into the epidural space of the spine may result in rare but serious adverse events,
including loss of vision,
stroke,
paralysis,
and death.
In recent years,
dexamethasone,
a non-particulate steroid,
has recently emerged as a drug for ESI.
Previous reports have described the frequency and type of ESI-related adverse events,
but the duration of use of dexamethasone is relatively short and the associated adverse events have not yet been fully elucidated.
The purpose of this study is to investigate the incidence and types of systemic adverse reactions associated with fluoroscopically guided ESI with dexamethasone.